Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in EuropeElise R. A. Pennings, Simone Oerlemans, Anna Fleischer et al.|Blood Advances|2025Cited by 3
The European CAR‐T map—Current status and future directions to improve access to CAR T‐cell therapy for hematologic malignanciesElise R. A. Pennings, Marie José Kersten, Frederick W. Thielen et al.|HemaSphere|2026Cited by 2